Richard Pzena - Pzena Investment Management
Holding/activity history for Halozyme Therapeutics, Inc. (HALO)
← All HALO superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 4,049 | <0.01 | Reduce 5.35% | $61.33–82.22 · VW $70.47i | $261,687 | SEC | |
| 2025 Q4 | 4,278 | <0.01 | Add 4.16% | $61.23–76.30 · VW $68.51i | $287,909 | SEC | |
| 2025 Q3 | 4,107 | <0.01 | Buy | <0.01 | $51.78–79.50 · VW $68.03i | $301,207 | SEC |
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $29.85–38.80 · VW $33.77i | SEC | |
| 2023 Q1 | 9,216 | <0.01 | Reduce 36.47% | <0.01 | $32.83–57.00 · VW $45.36i | $351,959 | SEC |
| 2022 Q4 | 14,507 | <0.01 | Buy | <0.01 | $39.17–59.46 · VW $52.48i | $825,448 | SEC |
| 2022 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | $36.95–48.58 · VW $43.56i | SEC | |
| 2022 Q1 | 15,738 | <0.01 | Buy | <0.01 | $31.36–42.33 · VW $36.46i | $628,000 | SEC |
Price snapshot:
Current price$76.11
Avg. buy price$73.10
+/- since buy4.12%
52-week low$55.64
52-week high$82.26